1. Home
  2. EOD vs CDXS Comparison

EOD vs CDXS Comparison

Compare EOD & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Global Dividend Opportunity Fund of Beneficial Interest

EOD

Allspring Global Dividend Opportunity Fund of Beneficial Interest

HOLD

Current Price

$6.49

Market Cap

271.7M

Sector

Finance

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.78

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EOD
CDXS
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
271.7M
256.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
EOD
CDXS
Price
$6.49
$2.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
121.0K
1.4M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
9.28%
N/A
EPS Growth
N/A
43.82
EPS
N/A
N/A
Revenue
N/A
$138,590,000.00
Revenue This Year
N/A
$7.73
Revenue Next Year
N/A
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$5.14
$0.96
52 Week High
$6.49
$3.87

Technical Indicators

Market Signals
Indicator
EOD
CDXS
Relative Strength Index (RSI) 64.58 62.29
Support Level $5.56 $2.37
Resistance Level N/A $2.92
Average True Range (ATR) 0.12 0.21
MACD 0.00 -0.03
Stochastic Oscillator 95.71 71.32

Price Performance

Historical Comparison
EOD
CDXS

About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest

Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: